NFL Investigates Jalen Hurts Blood Clot Diagnosis Amidst Medical Staff Scrutiny

The National Football League (NFL) has confirmed it is working with the NFL Players Association (NFLPA) to investigate the handling of Philadelphia Eagles quarterback Jalen Hurts' blood clot diagnosis. The situation has drawn scrutiny after Hurts was allowed to play despite the serious medical condition, which has ended his season and raised concerns about his career.

Hurts was diagnosed with multiple blood clots in his lungs last week, an ailment that has ruled him out for the remainder of the current season. This diagnosis has cast significant doubt over the future of the Eagles' $255 million quarterback.

The circumstances leading up to the diagnosis have become a focal point. Reports indicate that Hurts played in the Eagles' game against the Jacksonville Jaguars in London shortly after a hospital stay, having reportedly slept little the night before. He was initially diagnosed in London with superficial vein thrombosis in his left calf, but further testing revealed a deeper issue: deep vein thrombosis (DVT) and bilateral pulmonary emboli, which are clots in his lungs.

Concerns have been amplified by the decision to allow Hurts to fly back to the United States following the diagnosis. One medical expert described the decision as "reckless on a catastrophic level" to the Daily Mail.

The NFLPA officially called for a "full investigation" into Hurts' medical situation earlier this week. In response, an NFL spokesperson stated that the league and the players' association are collaborating to review the matter.

The news of Hurts' condition led to strong criticism of the Eagles' medical team. One expert told the Daily Mail that allowing him to play in the game was "the craziest decision that I can fathom" and suggested that "there has to be a fall guy, probably, multiple fall guys."

However, top NFL officials have pushed back against what they described as "nonsense" and "considerable and uninformed speculation" surrounding Hurts' injury. Dr. Allen Sills, the NFL's Chief Medical Officer, defended the medical staff, stating that "at every moment, with the patient’s best interests at heart, regardless of their identity."

Sills expressed his "complete confidence in the Eagles' medical staff and their handling of this situation," characterizing their approach as "very conservative, very patient-focused and appropriately guarded at every step." He added that the outcome does not necessarily indicate a flawed process, as sometimes diseases can progress despite appropriate medical care. Sills emphasized the vigilance and conservative care provided, including state-of-the-art imaging in London, and noted that the conditions might have been identified more readily in an athlete due to heightened vigilance.